I am not an expert on treatment of pulmonary problems with

New Post Public Reply Private Reply Replies (1) Message Board
farrell Drano #64112
605
I am not an expert on treatment of pulmonary problems with inhaled medications, but I do understand much progress has been made.

The link I posted discussed some of the advances which have been made and will be made in the future. The quote below is from the abstract of the paper. The paper reviews more details of preparation of inhaled pharmaceuticals including peptides for inhalation which of course is of interest if you are considering using Brilacidin as an inhaled medication.

https://www.ncbi.nlm.nih.gov/pubmed/26290195

" Examples of the production of therapeutic {inhaled}
particles for delivery of peptides, antibiotics, anticancer drugs, and the structures of particles obtained with the above mentioned and other methods are presented. The paper concludes with brief information about a recent construction of DPIs for aerosolization of therapeutic particles."

After all many thought it would be impossible to make an inhaler for any peptide much less one much more complex than Brilacidin,but insulin was prepared as a successful treatment for diabetes. An inhaled insulin has been available for some time.

Diabetes Technol Ther. 2018 Oct;20(10):639-647. doi: 10.1089/dia.2018.0200. Epub 2018 Sep 15.

I do not believe your arguments against inhalers will have much influence on scientists seeking improved methods of drug delivery for pulmonary or systemic diseases

https://www.ncbi.nlm.nih.gov/pubmed/28846876
https://www.ncbi.nlm.nih.gov/pubmed/26290195

If IV Brilacidin is effective for treatment of Covid 19 an inhaler will be studied. If an inhaler is developed it will be also studied for a number of pulmonary disorders including asthma, COPD, bronchitis, cystic fibrosis, pulmonary fibrosis and others.

All in my opinion

Good luck,Farrell

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Fox Factory Stock Hits Record Low with Strategic Adjustments

Updated Category News Views 104

Market Challenges and Stock Performance Fox Factory Holding Corp (NASDAQ: FOXF) has recently seen its stock sink to a 52-week low, reaching $28.92. This downturn reflects the challenging market conditions the company is currently facing. With a market capitalization of $1.2 billion and a price-to-earnings (P/E) ratio of 113, FOXF now trades below its fair value. Over the...

Continue Reading
Entropy Robotics Partners with SRI for Innovative Navigation

Updated Category News Views 205

Entropy Robotics Partners with SRI for Innovative Navigation Entropy Robotics, an innovative startup focused on AI-driven solutions for robotics and drones, has recently formed a strategic partnership with SRI, an independent nonprofit research organization. This collaboration aims to enhance autonomous navigation capabilities for robots operating in challenging...

Continue Reading
Legal Opportunities for Quanex Building Products Investors

Updated Category News Views 130

Investment Legal Options for Quanex Building Products Corporation Bronstein, Gewirtz & Grossman, LLC, a leading law firm in investor representation, has announced a significant opportunity for shareholders of Quanex Building Products Corporation (NYSE: NX). Investors who have incurred considerable losses are being invited to participate and potentially lead a class action...

Continue Reading
Braskem Launches Sustainable Bio-Circular Polypropylene for Food Industry

Updated Category News Views 82

Braskem's Innovative Sustainability Effort Braskem (B3: BRKM3, BRKM5, and BRKM6; NYSE: BAK) has launched an exciting new sustainable product—bio-circular polypropylene (PP), known as WENEW. As the top producer of polyolefins in the Americas, Braskem is raising the bar by offering this eco-friendly solution specifically designed for the restaurant and snack food...

Continue Reading
Exploring the Growth of Direxion Daily Semiconductor Shares

Updated Category News Views 136

Understanding Direxion Daily Semiconductor Bull 3X Shares Direxion Daily Semiconductor Bull 3X Shares (NYSE: SOXL) has delivered impressive returns over the past 15 years, outperforming the general market by a remarkable 29.99% on an annualized basis. The fund boasts an average annual return of 41.86%, showcasing its strength in the technology sector, which continues to...

Continue Reading